Karuna is a clinical-stage biopharmaceutical company committed to developing and delivering first-in-class therapies with the potential to transform the lives of people with CNS disorders – which remain among the most disabling and potentially fatal disorders worldwide. Galvanized by the understanding that today’s neuropsychiatric patients deserve better, Karuna’s mission is to harness the untapped potential of the brain’s complex biology in pursuit of novel therapeutic pathways that will advance the standard of care.

Biotechnology

Karuna Therapeutics

Bill Meury

Steven Paul

Tanya Glidden

Amanda Orban

Stephanie Hodges

Alicia Meli

Frank Truslow

Jackie Cohen

Gregg Pratt

Mia Kelley

Will Kane

Andrew Miller

Troy A. Ignelzi

Stephen Brannan

The Scientific and Research Team at Karuna Therapeutics is responsible for pioneering innovative research to develop novel therapies for CNS disorders. Comprising senior leaders and experts in medical and scientific disciplines, the team focuses on discovering and advancing new therapeutic pathways. Their work aims to enhance the standard of care and bring transformative treatments to patients suffering from neuropsychiatric conditions.

Scientific and Research Team

Medical and Clinical Operations

Directors

Leadership Team

��

Scientific and Research Team

About

Team members

Other teams at Karuna Therapeutics

Medical and Clinical Operations

Directors

Leadership Team

��������

Scientific and Research Team

About

Team members

Other teams at Karuna Therapeutics

Medical and Clinical Operations

Directors

Leadership Team

��